These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 3123643

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Extrapancreatic effects of sulfonylurea compounds. IV. Increase of the effect of insulin due to tolbutamide, glibornuride, and glibenclamide in vitro].
    Beyer J, Gather W, Schöffling K.
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2179. PubMed ID: 4198966
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Clark HE, Matthews DR.
    Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents?
    Marble A.
    Drugs; 1971 Sep; 1(2):109-15. PubMed ID: 4999930
    [No Abstract] [Full Text] [Related]

  • 31. The pharmacology of a new hypoglycaemic agent N-[4-(2-(2,3-dihydrobenzo(b)furan-m-carboxamido)-ethyl)-benzenesulphonyl]-N'-cyclohexylurea (NOVO CS 476). I. Pharmacological studies on the hypoglycaemic effect.
    Jorgensen KD.
    Acta Pharmacol Toxicol (Copenh); 1977 Feb; 40(2):216-26. PubMed ID: 402791
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Insulin secretion after oral and intravenous administration of various 1st and 2d generation sulfonylurea derivatives in equipotential dosage].
    Haupt E, Köberich W, Rosak C, Cordes U, Beyer J, Schöffling K.
    Verh Dtsch Ges Inn Med; 1972 Feb; 78():1272-5. PubMed ID: 4198780
    [No Abstract] [Full Text] [Related]

  • 34. Interacting effects of sulfonylureas and glucose on cyclic AMP metabolism and insulin release in pancreatic islets of the rat.
    Grill V, Cerasi E.
    J Clin Invest; 1978 May; 61(5):1346-54. PubMed ID: 207736
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Biochemical and morphological events associated with the development of fetal rat pancreas "in vivo" and "in vitro": effect of glucagon and of other agents.
    Lambert AE, Orci L, Kanazawa Y, Jeanrenaud B, Renold AE.
    Acta Isot (Padova); 1970 May; 10(3):191-204. PubMed ID: 4334397
    [No Abstract] [Full Text] [Related]

  • 40. Different effects of prostaglandin E1, E2 and D2 on pancreatic somatostatin release.
    Nishi S, Seino Y, Seino S, Tsuda K, Takemura J, Shimizu T, Hayashi O, Imura H.
    Horm Metab Res; 1984 Dec; 16 Suppl 1():114-8. PubMed ID: 6152434
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.